Medpace Holdings, Inc. vs Abbvie Inc.
MEDP vs ABBV — side-by-side comparison from reported financials. MEDP leads 5, ABBV leads 4 of 9 comparable metrics.
Medpace Holdings, Inc.
MEDP · Healthcare
$612.05+1.55%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | MEDP | ABBV |
|---|---|---|
| Price | $612.05 | $276.43 |
| Market cap | $17.1B | $488B |
| Revenue (TTM) | $2.78B | $64.4B |
| Revenue growth | +20.1% | +1.8% |
| Net margin | 17.7% | 9.8% |
| Free cash flow | $707M | $18.2B |
| Net cash (debt) | — | ($56.2B) |
| 1-year price return | +18.0% | +19.8% |
| P/E | 34.8 | 77.4 |
| P/E vs own history (cheap-side %) | 30% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 110% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 8 of 10 | 9 of 10 |
| Employees | 6,500 | 57,000 |
Full résumé-style profiles: MEDP CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.